142932682 Stock Overview

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. More details

142932682 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	5/6
Financial Health	4/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (26.1x) is below the Life Sciences industry average (30.8x)

Earnings are forecast to grow 9.8% per year

Earnings grew by 41.9% over the past year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Siegfried Holding AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Siegfried Holding
Historical stock prices
Current Share Price	CHF 93.00
52 Week High	CHF 0
52 Week Low	CHF 0
Beta	0.70
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	142932682	CH Life Sciences	CH Market
7D	0%	-2.7%	-0.9%
1Y	n/a	-4.0%	2.0%

Return vs Industry: Insufficient data to determine how 142932682 performed against the Swiss Life Sciences industry.

Return vs Market: Insufficient data to determine how 142932682 performed against the Swiss Market.

Price Volatility

Is 142932682's price volatile compared to industry and market?
142932682 volatility
142932682 Average Weekly Movement	n/a
Life Sciences Industry Average Movement	5.1%
Market Average Movement	4.8%
10% most volatile stocks in CH Market	9.4%
10% least volatile stocks in CH Market	2.5%

Stable Share Price: 142932682's share price has been volatile over the past 3 months compared to the Swiss market.

Volatility Over Time: Insufficient data to determine 142932682's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1873	3,886	Marcel Imwinkelried	www.siegfried.ch

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. The company offers drug substances, including exclusive synthesis that manufactures custom APIs. It also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition.

Siegfried Holding AG Fundamentals Summary

How do Siegfried Holding's earnings and revenue compare to its market cap?
142932682 fundamental statistics
Market cap	CHF 4.18b
Earnings (TTM)	CHF 160.06m
Revenue (TTM)	CHF 1.29b

26.1x

P/E Ratio

3.2x

P/S Ratio

Is 142932682 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
142932682 income statement (TTM)
Revenue	CHF 1.29b
Cost of Revenue	CHF 965.52m
Gross Profit	CHF 329.06m
Other Expenses	CHF 168.99m
Earnings	CHF 160.06m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 21, 2025

Earnings per share (EPS)	3.66
Gross Margin	25.42%
Net Profit Margin	12.36%
Debt/Equity Ratio	50.0%

How did 142932682 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

10%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/25 13:40
End of Day Share Price	2025/04/25 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Siegfried Holding AG is covered by 22 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Leonildo Delgado	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research
Thomas Meyer	Baader Helvea Equity Research